litlas
ログインアカウント作成

David L. Kendler

1993–2025 年に発表

86
論文数
18,801
被引用数
67
h 指数
84
i10 指数

被引用数

David L. Kendler の年別被引用数1994 年: 被引用 2 件1995 年: 被引用 2 件1996 年: 被引用 3 件1997 年: 被引用 1 件1998 年: 被引用 14 件1999 年: 被引用 16 件2000 年: 被引用 24 件2001 年: 被引用 38 件2002 年: 被引用 40 件2003 年: 被引用 48 件2004 年: 被引用 42 件2005 年: 被引用 53 件2006 年: 被引用 88 件2007 年: 被引用 62 件2008 年: 被引用 97 件2009 年: 被引用 71 件2010 年: 被引用 127 件2011 年: 被引用 119 件2012 年: 被引用 137 件2013 年: 被引用 104 件2014 年: 被引用 106 件2015 年: 被引用 116 件2016 年: 被引用 154 件2017 年: 被引用 138 件2018 年: 被引用 191 件2019 年: 被引用 543 件2020 年: 被引用 674 件2021 年: 被引用 553 件2022 年: 被引用 450 件2023 年: 被引用 315 件2024 年: 被引用 525 件2025 年: 被引用 275 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,332 件、この内訳の 21.3%イギリス: 引用元論文 480 件、この内訳の 7.7%中国: 引用元論文 389 件、この内訳の 6.2%カナダ: 引用元論文 348 件、この内訳の 5.6%イタリア: 引用元論文 343 件、この内訳の 5.5%オーストラリア: 引用元論文 265 件、この内訳の 4.3%ドイツ: 引用元論文 258 件、この内訳の 4.1%日本: 引用元論文 223 件、この内訳の 3.6%スイス: 引用元論文 221 件、この内訳の 3.5%ベルギー: 引用元論文 214 件、この内訳の 3.4%フランス: 引用元論文 198 件、この内訳の 3.2%オランダ: 引用元論文 177 件、この内訳の 2.8%
0%21.3%その他 28.8%

機関

分野

  • Medicine82.1%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Engineering1.8%
  • Immunology and Microbiology0.6%
  • Health Professions0.5%
  • Dentistry0.5%
  • その他2.2%

トピック

  • Bone health and osteoporosis research19.1%
  • Bone health and treatments15.1%
  • Bone Metabolism and Diseases9.7%
  • Bone and Joint Diseases6.5%
  • Hip and Femur Fractures3.4%
  • Parathyroid Disorders and Treatments2.9%
  • その他43.3%

共著者

全論文

検索で開く
  1. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

    著者: Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi, Jacques P. Brown, Roland Chapurlat, Steven R. Cummings, E. J. Czerwiński, Astrid Fahrleitner‐Pammer, David L. Kendler, Kurt Lippuner, Jean‐Yves Reginster, Christian Roux, Jorge Malouf, Michelle N. Bradley, Nadia Daizadeh, Andrea Wang, Paula Dakin, Nicola Pannacciulli, David W. Dempster, Socrates E. Papapoulos - The Lancet Diabetes & Endocrinology 2017 被引用: 961

  2. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

    著者: Bente Langdahl, Cesar Libanati, Daria B. Crittenden, Michael A. Bolognese, Jacques P. Brown, Nadia Daizadeh, Eva Dokoupilová, Klaus Engelke, Joel S. Finkelstein, Harry K. Genant, Stefan Goemaere, Lars Hyldstrup, Esteban Jódar-Gimeno, Tony M. Keaveny, David L. Kendler, Péter Lakatos, Judy Maddox, Jorge Malouf, Fabio Massari, José Fernando Molina, María Rosa Ulla, Andreas Grauer - The Lancet 2017 被引用: 467

  3. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

    著者: David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini, Luis Augusto Tavares Russo, Susan L. Greenspan, Vı́t Zikán, A. Bagur, Jorge Malouf-Sierra, Péter L. Lakatos, Astrid Fahrleitner‐Pammer, Éric Lespessailles, Salvatore Minisola, J.J. Body, Piet Geusens, R Möricke, Pedro López‐Romero - The Lancet 2017 被引用: 581

  4. Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

    著者: Aliya Khan, Archie Morrison, David A. Hanley, Dieter Felsenberg, Laurie K. McCauley, Felice O’Ryan, Ian R. Reid, Salvatore L. Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B. Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M. Cheung, Suzanne N. Morin, Basel Masri, Cyrus Cooper, Sarah Morgan, Barbara Obermayer‐Pietsch, Bente Langdahl, Rana Al Dabagh, Kelly Davison, David L. Kendler, George K.B. Sándor, Robert G. Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D. Pierroz, Riad A. Sulimani, Deborah Saunders, Jacques P. Brown, Juliet Compston, on behalf of the International Task Force on Osteonecrosis of the Jaw - Journal of Bone and Mineral Research 2014 被引用: 1,345

  5. Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review

    著者: David L. Kendler, Felicia Cosman, Robert Stad, Serge Ferrari - Advances in Therapy 2021 被引用: 212

  6. Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

    著者: Henry G. Bone, Michael A. Bolognese, Chui Kin Yuen, David L. Kendler, Paul D. Miller, YuChing Yang, Luanda Grazette, Javier San Martín, John C. Gallagher - The Journal of Clinical Endocrinology & Metabolism 2011 被引用: 611

  7. Romosozumab and antiresorptive treatment: the importance of treatment sequence

    著者: Felicia Cosman, David L. Kendler, Bente Langdahl, Benjamin Z. Leder, E. Michael Lewiecki, Akimitsu Miyauchi, Maria Rojeski, Michele McDermott, Mary Oates, Cassandra E. Milmont, Cesar Libanati, Serge Ferrari - Osteoporosis International 2022 被引用: 111

  8. Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab

    著者: David L. Kendler, Henry G. Bone, Francesco Massari, Evelien Gielen, Santiago Palacios, Judy Maddox, Chao Yan, Susan Yue, Rajani Dinavahi, Cesar Libanati, Andreas Grauer - Osteoporosis International 2019 被引用: 122

  9. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

    著者: David L. Kendler, Christian Roux, Claude Laurent Benhamou, Jacques P. Brown, Michael Lillestol, Suresh Siddhanti, H Man, Javier San Martín, Henry G. Bone - Journal of Bone and Mineral Research 2009 被引用: 451

  10. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

    著者: Nicholas C. Harvey, Claus‐Christian Glüer, Neil Binkley, Eugène McCloskey, Maria Luisa Brandi, Cyrus Cooper, David L. Kendler, Olivier Lamy, Andrea Laslop, Bruno Muzzi Camargos, J.-Y. Reginster, René Rizzoli, J. A. Kanis - Bone 2015 被引用: 473

  11. Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

    著者: Michael R. McClung, Steven T. Harris, Paul D. Miller, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, David L. Kendler, Chui Kin Yuen, E. Michael Lewiecki - The American Journal of Medicine 2012 被引用: 453

  12. Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

    著者: on behalf of the DAPS Investigators, Nick Freemantle, Sacha Satram‐Hoang, En‐Tzu Tang, Primal Kaur, David Macarios, Suresh Siddhanti, Jeff Borenstein, David L. Kendler - Osteoporosis International 2011 被引用: 283

  13. Vertebral Fractures: Clinical Importance and Management

    著者: David L. Kendler, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, S. T. Harris, Michael R. McClung, Paul D. Miller, John T. Schousboe, Chui Kin Yuen, E. Michael Lewiecki - The American Journal of Medicine 2015 被引用: 315

  14. Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

    著者: Anthony B. Hodsman, Douglas C. Bauer, David W. Dempster, Larry Dian, David A. Hanley, Steven T. Harris, David L. Kendler, Michael R. McClung, Paul D. Miller, Wojciech P. Olszynski, Eric Orwoll, Chui Kin Yuen - Endocrine Reviews 2005 被引用: 721

  15. Bone Mineral Density After Transitioning From Denosumab to Alendronate

    著者: David L. Kendler, Arkadi Chines, Patricia Clark, Peter R. Ebeling, Michael R. McClung, Yumie Rhee, Shuang Huang, Robert Stad - The Journal of Clinical Endocrinology & Metabolism 2019 被引用: 113

  16. Alendronate for the Treatment of Osteoporosis in Men

    著者: Eric Orwoll, Mark P. Ettinger, Stuart Weiss, Paul D. Miller, David L. Kendler, John Graham, Silvano Adami, Kurt Weber, R Lorenc, Peter Pietschmann, Kristel Vandormael, Antonio Lombardi - New England Journal of Medicine 2000 被引用: 977

  17. Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease

    著者: Aaron Broadwell, Arkadi Chines, Peter R. Ebeling, Edward Franek, Shuang Huang, Shawna Smith, David L. Kendler, Osvaldo Daniel Messina, Paul D. Miller - The Journal of Clinical Endocrinology & Metabolism 2020 被引用: 88

  18. The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial

    著者: E. J. Czerwiński, José Cardona, Rafal Plebanski, Chris Recknor, Tamara Vokes, Kenneth G. Saag, Neil Binkley, E. Michael Lewiecki, Jonathan D. Adachi, Dorota Knychas, David L. Kendler, Eric Orwoll, Yinzhong Chen, Leny Pearman, Y Heather Li, Bruce Mitlak - Journal of Bone and Mineral Research 2020 被引用: 43

  19. Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis

    著者: Adolfo Díez‐Pérez, Fernando Marín, Erik Fink Eriksen, David L. Kendler, John H. Krege, Miguel Delgado‐Rodríguez - Bone 2018 被引用: 111

  20. Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors

    著者: Gemma Marcucci, Giovanni Beltrami, A. Tamburini, Jean‐Jacques Body, C Confavreux, Peyman Hadji, Gerold Holzer, David L. Kendler, Nicola Napoli, Dominique D. Pierroz, R. Rizzoli, Maria Luisa Brandi - Annals of Oncology 2019 被引用: 85

  21. Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women

    著者: Henry G. Bone, Michael A. Bolognese, Chui Kin Yuen, David L. Kendler, Huei Wang, Yu Liu, Javier San Martín - The Journal of Clinical Endocrinology & Metabolism 2008 被引用: 427

  22. Lasofoxifene in Postmenopausal Women with Osteoporosis

    著者: Steven R. Cummings, Kristine E. Ensrud, Pierre D. Delmas, Andrea Z. LaCroix, Slobodan Vukičević, David M. Reid, Steven R. Goldstein, Usha Sriram, Andy Lee, John R. Thompson, Róisín Armstrong, David D. Thompson, Trevor J. Powles, José Zanchetta, David L. Kendler, Patrick Neven, Richard Eastell - New England Journal of Medicine 2010 被引用: 383

  23. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

    著者: E. Michael Lewiecki, Catherine M. Gordon, Sanford Baim, Mary B. Leonard, Nicholas Bishop, Maria-Luisa Bianchi, Heidi J. Kalkwarf, Craig B. Langman, Horatio Plotkin, Frank Rauch, Babette S. Zemel, Neil Binkley, John P. Bilezikian, David L. Kendler, Didier Hans, Stuart Silverman - Bone 2008 被引用: 577

  24. Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ

    著者: Aliya Khan, Archie Morrison, David L. Kendler, René Rizzoli, David A. Hanley, Dieter Felsenberg, Laurie K. McCauley, Felice O’Ryan, Ian R. Reid, Salvatore L. Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B. Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M. Cheung, Suzanne N. Morin, Basel Masri, Cyrus Cooper, Sarah L. Morgan, Barbara Obermayer‐Pietsch, Bente Langdahl, Rana Al Dabagh, Kelly Davison, George K.B. Sándor, Robert G. Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D. Pierroz, Riad A. Sulimani, Deborah Saunders, Jacques P. Brown, Juliet Compston - Journal of Clinical Densitometry 2016 被引用: 263